Little Pink Pill | WBEZ
Skip to main content

On The Media

Little Pink Pill

Last August, Flibanserin -- or "Addyi" -- became the first FDA-approved drug aimed at treating sexual dysfunction in women. Sprout, the company that developed the so-called “female Viagra” was understandably excited, and even more so the next day when they were bought by pharmaceutical giant Valeant, for one billion dollars. But after a rocky year, Valeant announced Monday that they had dismissed the entire sales force associated with Flibanserin and would reintroduce the drug later in the year. When Flibanserin first hit the shelves last year, we took a deep dive into its marketing message and the nebulous world of prescription drugs and female desire. 

Get the WBEZ App

Download the best live and on-demand public radio experience. Find out more.

CLOSE X